Validation of Disability Status, a Claims-based Measure of Functional Status for Cancer Treatment and Outcomes Studies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Validation of Disability Status, a Claims-based Measure of Functional Status for Cancer Treatment and Outcomes Studies

Published:2014-06 Issue:6 Volume:52 Page:500-510
ISSN:0025-7079
Container-title:Medical Care
language:en
Short-container-title:

Author:

Davidoff Amy J.,Gardner Lisa D.,Zuckerman Ilene H.,Hendrick Franklin,Ke Xuehua,Edelman Martin J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Public Health, Environmental and Occupational Health

Reference11 articles.

1. Assessing comorbidity using claims data: an overview.;Klabunde;Med Care,2002

2. Patients with advanced non-small-cell lung cancer and marginal performance status: walking the tight rope towards improved survival.;West;J Clin Oncol,2013

3. A profile of the Medicare Current Beneficiary Survey.;Adler;Health Care Financ Rev,1994

4. Black-white differences in self-reported disability outcomes in the US: early childhood to older adulthood.;Nuru-Jeter;Public Health Rep,2011

5. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.;Deyo;J Clin Epidemiol,1992

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of high-intensity care at the end of life among older adults with solid tumors: A population-based study;Journal of Geriatric Oncology;2024-06

2. Association of cancer diagnosis with disability status among older survivors of colorectal cancer: a population-based retrospective cohort study;Frontiers in Oncology;2024-03-15

3. Exploring Indicators of Vulnerability in Older Adults With Newly Diagnosed Multiple Myeloma;JCO Clinical Cancer Informatics;2024-03

4. Incidence and risk factors of immune‐related adverse events induced by immune checkpoint inhibitors among older adults with non‐small cell lung cancer;Cancer Medicine;2024-01

5. Real-World Survival of First-Line Immune Checkpoint Inhibitor Treatment Versus Chemotherapy in Older Patients With Non–Small-Cell Lung Cancer and Synchronous Brain Metastases;JCO Oncology Practice;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3